Search

everythinglearnresearchcommunity

for

Search:↓

The treatment with valproate, acetylcarnitine, folic acid, and vitamin B12 may improve muscle strength in children with SMA without significant side effects.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Dupilumab can cause psoriasis in some patients.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

ASC-CM is more effective than EV for treating osteoarthritis.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Methotrexate effectively managed SAPHO syndrome symptoms when other treatments failed.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Blocking certain immune signals can reduce skin damage from radiation therapy.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

The patient had paraneoplastic pemphigus without mucosal involvement.

The anti-CXCL4 antibody helps mice grow hair faster and prevents hair loss.